Hrishikesh Kumar

Dr. Hrishikesh Kumar

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2021 in Toxins
Verified
Journal Article
Open access
PDF file
SCSupriyo Choudhury
Supriyo Choudhury
MBMark Baker
Mark Baker
SCSuparna Chatterjee
Suparna Chatterjee
HKHrishikesh Kumar
Hrishikesh Kumar
Since its introduction as a treatment for strabismus, botulinum toxin (BoNT) has had a phenomenal journey and is now recommended as first-line treatment for focal dystonia, despite short-term clinical benefits and the risks of adverse effects. To cater for the high demand across various medical specialties, at least six US Food and Drug Administration (FDA)-approved formulations of BoNT are currently available for diverse labelled indications. The toxo-pharmacological properties of these formulations are not uniform and thus should not be used interchangeably. Synthetic BoNTs and BoNTs from non-clostridial sources are not far from clinical use. Moreover, the study of mutations in naturally occurring toxins has led to modulation in the toxo-pharmacokinetic properties of BoNTs, including the duration and potency. We present an overview of the toxo-pharmacology of conventional and novel BoNT preparations, including those awaiting imminent translation from the laboratory to the clinic.

1 January 2020 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
KCKoustav Chatterjee
Koustav Chatterjee
ARAkash Roy
Akash Roy
RBRebecca Banerjee
Rebecca Banerjee
SCSupriyo Choudhury
Supriyo Choudhury
BMBanashree Mondal
Banashree Mondal
HKHrishikesh Kumar
Hrishikesh Kumar

1 April 2018 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
IRIvan Rektor
Ivan Rektor
NBNicolaas I. Bohnen
Nicolaas I. Bohnen
AKAmos D. Korczyn
Amos D. Korczyn
VGViktoria Gryb
Viktoria Gryb
HKHrishikesh Kumar
Hrishikesh Kumar
BVBranislav Veselý
Branislav Veselý

8 October 2021 in Movement Disorders
Verified
Journal Article
Open access
PDF file
FMFrancesca Magrinelli
Francesca Magrinelli
SMSahil Mehta
Sahil Mehta
GLGiulia Di Lazzaro
Giulia Di Lazzaro
Anna LatorreAnna Latorre
Anna Latorre
MEMark J. Edwards
Mark J. Edwards
KBKailash P. Bhatia
Kailash P. Bhatia
Background: Complex parkinsonism is the commonest phenotype in late‐onset PLA2G6‐associated neurodegeneration.Objectives: The aim of this study was to deeply characterize phenogenotypically PLA2G6‐related parkinsonism in the largest cohort ever reported.Methods: We report 14 new cases of PLA2G6‐related parkinsonism and perform a systematic literature review.Results: PLA2G6‐related parkinsonism shows a fairly distinct phenotype based on 86 cases from 68 pedigrees. Young onset (median age, 23.0 years) with parkinsonism/dystonia, gait/balance, and/or psychiatric/cognitive symptoms were common presenting features. Dystonia occurred in 69.4%, pyramidal signs in 77.2%, myoclonus in 65.2%, and cerebellar signs in 44.6% of cases. Early bladder overactivity was present in 71.9% of cases. Cognitive impairment affected 76.1% of cases and psychiatric features 87.1%, the latter being an isolated presenting feature in 20.1%. Parkinsonism was levodopa responsive but complicated by early, often severe dyskinesias. Five patients benefited from deep brain stimulation. Brain magnetic resonance imaging findings included cerebral (49.3%) and/or cerebellar (43.2%) atrophy, but mineralization was evident in only 28.1%. Presynaptic dopaminergic terminal imaging was abnormal in all where performed. Fifty‐four PLA2G6 mutations have hitherto been associated with parkinsonism, including four new variants reported in this article. These are mainly nontruncating, which may explain the phenotypic heterogeneity of childhood‐ and late‐onset PLA2G6‐associated neurodegeneration. In five deceased patients, median disease duration was 13.0 years. Brain pathology in three cases showed mixed Lewy and tau pathology.Conclusions: Biallelic PLA2G6 mutations cause early‐onset parkinsonism associated with dystonia, pyramidal and cerebellar signs, myoclonus, and cognitive impairment. Early psychiatric manifestations and bladder overactivity are common. Cerebro/cerebellar atrophy are frequent magnetic resonance imaging features, whereas brain iron deposition is not. Early, severe dyskinesias are a tell‐tale sign. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

14 March 2019 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
BMBanashree Mondal
Banashree Mondal
SCSupriyo Choudhury
Supriyo Choudhury
BSBruce Simon
Bruce Simon
MBMark Baker
Mark Baker
HKHrishikesh Kumar
Hrishikesh Kumar

8 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JWJeffrey D. Wall
Jeffrey D. Wall
JSJ. Fah Sathirapongsasuti
J. Fah Sathirapongsasuti
RGRavi Gupta
Ravi Gupta
ARAsif Rasheed
Asif Rasheed
VRVenkatesan Radha
Venkatesan Radha
APAndrew S. Peterson
Andrew S. Peterson
The benefits of large-scale genetic studies for healthcare of the populations studied are well documented, but these genetic studies have traditionally ignored people from some parts of the world, such as South Asia. Here we describe whole genome sequence (WGS) data from 4806 individuals recruited from the healthcare delivery systems of Pakistan, India and Bangladesh, combined with WGS from 927 individuals from isolated South Asian populations. We characterize population structure in South Asia and describe a genotyping array (SARGAM) and imputation reference panel that are optimized for South Asian genomes. We find evidence for high rates of reproductive isolation, endogamy and consanguinity that vary across the subcontinent and that lead to levels of rare homozygotes that reach 100 times that seen in outbred populations. Founder effects increase the power to associate functional variants with disease processes and make South Asia a uniquely powerful place for population-scale genetic studies.